Schroder Investment Management Group
OLMA icon

Schroder Investment Management Group’s Olema Pharmaceuticals OLMA Stock Holding History

Schroder Investment Management Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
+114,192
New +$1.53M ﹤0.01% 980
2025
Q3 		– Sell
-618,184
Closed -$2.63M – 1241
2025
Q2 		$2.63M Buy
618,184
+85,073
+16% +$379K ﹤0.01% 874
2025
Q1 		$2.19M Hold
533,111
– – ﹤0.01% 897
2024
Q4 		$2.99M Buy
533,111
+450,924
+549% +$4.5M ﹤0.01% 867
2024
Q3 		$1M Sell
82,187
-77,552
-49% -$991K ﹤0.01% 1028
2024
Q2 		$1.73M Buy
+159,739
New +$1.73M ﹤0.01% 949

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Schroder Investment Management Group's OLMA Position: Q2 2026 in Review

Schroder Investment Management Group opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 114,192 shares worth $1.39M. The stake represents ﹤0.01% of the portfolio and ranks #980 among its holdings. This is a return to the name: Schroder Investment Management Group previously reported a position in OLMA as recently as Q2 2025.

Schroder Investment Management Group first reported a position in OLMA in Q2 2024 and has held it in 6 quarters since. The position peaked at $2.99M in Q4 2024. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Schroder Investment Management Group held 114,192 shares of Olema Pharmaceuticals worth $1.39M as of Q2 2026.
  • Olema Pharmaceuticals was a new Schroder Investment Management Group position in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #980 holding.
  • Schroder Investment Management Group first reported a position in Olema Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • Schroder Investment Management Group's Olema Pharmaceuticals position peaked at $2.99M in Q4 2024.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.